Investor

Presentation

H1 2026 report

1Rainbow Global

Spain Manufacturing Base U.S. Houston Champaign

Manufacturing Base Weifang Qingdao Ningxia Manufacturing Bases

Manufacturing Bases

Subsidiary / Office

R&D Centers

Weifang Jinan R&D Centers

Weifang Process Development Center

Argentina Manufacturing Base

10100+140+

Factories Operational Overseas

Countries Subsidiaries

380+5000+9400+

Independent Staffs Registrations

Patents Globally Globally2026 Crop Protection

Industry Status

Active ingredient prices experienced short-term

volatility.Supply-side competition intensifies pressuring margins;

leading companies see channel gross margin recovery.Exports remain resilient supported by continued policy

optimization and accelerating formulation product

exports.Channels increasingly favor low inventory and delayed

procurement.Generic crop protection share rises driving Chinese

exporters' global growth.Falling end-user returns and rising credit risk along the

industrial chain.Industry Overview

Export Volume Trends of Products Under China HS Code 3808

10k Tons 2026 2025 2024 2023

40.00

36.17

33.89

35.00

33.71

30.86

30.2930.13

30.0030.4728.4330.86

27.4828.6227.6425.4726.1726.9327.2425.1824.92

25.0025.0124.4825.19

23.11

22.3324.8622.2124.06

22.9922.9922.54

20.0018.9021.8319.75

17.4319.57

18.7719.25

17.2117.10

15.0014.39

15.41

11.9514.43

10.00

123456789101112

10k Tons

H1 2026: Total export volume increased by 15.66% YoY

Q2 2026: Total export volume increased by 16.65% YoYIndustry Overview

Export Value Trends of Products Under China HS Code 3808

Hundred 2026 2025 2024 2023

Million USD

12.00

11.0010.95

10.13

10.009.77

9.10

9.008.808.798.84

8.12

7.918.18

8.007.857.887.697.647.717.67

7.027.447.277.28

7.267.657.71

7.006.657.156.756.66

6.946.326.92

6.586.65

6.00

5.536.126.41

6.07

5.425.90

4.945.60

5.005.41

4.59

4.00

3.00

2.00

123456789101112

Hundred

Million USD

H1 2026: Total export value increases by 18.75 % YoY

Q2 2026: Total export value increased by 22.26% YoYIndustry Overview

Export Unit Price Trends of Products Under China HS Code 3808

2026202520242023

USD/Kg

5.00

4.57

4.50

4.134.17

4.003.88

3.59

3.50

3.173.153.263.273.25

2.983.043.033.043.073.083.01

3.002.872.922.973.143.002.792.813.05

2.862.812.99

2.692.923.022.852.962.922.962.872.752.85

2.86

2.502.672.602.70

2.00

1.50

1.00

0.50

-

USD/Kg 1 2 3 4 5 6 7 8 9 10 11 12

H1 2026: Monthly average export unit price increased from $ 2.86/kg in January

to $ 3.25/kg in JunePerformance Overview

Core Business

Revenue Growing Gross Margin Rate EBITDA Increasing

Profitability Improving

Steadily Steadily Improving Significantly

Significantly

Revenue at RMB 7.442 billion Gross margin increased to EBITDA at RMB 1.173 billion Net profit attributable to the parent

+13.95% YoY 24.29% (+2.87pp YoY) +43.82% YoY growing faster than at RMB 502 million down 9.67%

revenue confirming the YoY impacted by exchange rate

Growth driven by deeper global Driven by a rising Model C strengthening of high-quality fluctuations and changes in fair

market penetration (rapid business and im0proved margins growth drivers. value of FX derivatives.expansion in North America and across all product lines reflecting

the EU) and resilient existing steady progress in profit structure Excluding FX-related impacts core

business further strengthening the optimization. business profitability improved

operating base. significantly YoY reflecting the

continued strengthening of core

competitiveness.Performance Overview

Revenue Up YoY Reflecting Continued Market

Expansion and Deepening Success

Revenue Comparison Asia Oceania Europe & Brazil and Latin

Middle East and

North American America

Africa

Unit: RMB billion

Early-stage Deeper0 market Revenue slightly down

+13.95% expansion with penetration driving YoY due to delayed

steadily growing steady growth procurement season

80.00 7.442 80.00 revenue

70.006.53170.00

60.0060.00+10.56%

50.0050.00

4.25

3.844

40.0040.00

30.0030.00

20.0020.00

10.0010.00

0.000.00

H1 2025 H1 2026 Q2 2025 Q2 2026Performance Overview

Gross Margin Rate Up YoY

Reflecting Improving Earnings Quality.Gross Margin Rate Comparison

1. Model C revenue increased by 7.63 pct

Rising from 40.14% to 47.77% with clear contribution from business mix

optimization

+ 175bps 2. Non-herbicide category up by 0.91pct+ 287bps

30.00% 30.00% Rising from 27.95% to 28.86% achieving more balanced growth

24.29%24.67%

25.00% 25.00% 22.92% 3. North America/Europe high-value markets steadily ramping up21.42%

In early expansion stage with sustained growth momentum

20.00%20.00%

4. In-House active ingredients projects delivered smart 15.00% 15.00%

manufacturing cost reductions evident

10.00% 10.00% In-house active ingredients technical upgrades and new project execution

combined with lean smart manufacturing in formulation serve as a dual-

5.00%5.00%

engine driving cost reduction and efficiency gains. Gross margins

0.00% 0.00% improved across all business models and product categories

H1 2025 H1 2026 Q2 2025 Q2 2026Performance Overview

EBITDA And EBITDA Margin Up YoY

Core Operating Efficiency Strengthening

EBITDA Comparison EBITDA Margin Comparison

Unit: RMB million

18.00%16.54%

14.00+43.82%14.0016.00%14.72%

13.99%14.13%

117313.57%

12.0012.0014.00%

12.00%

10.0010.00+30.65%10.33%

81510.00%

8.008.00703

8.00%

6.006.00538

6.00%

4.004.00

4.00%

2.002.002.00%

0.000.000.00%

H1 2025 H1 2026 Q2 2025 Q2 2026 Q1 2025 Q2 2025 Q3 2025 Q4 2025 Q1 2026 Q2 2026Performance Overview

Net Profit Attributable To The Owner Of Parent Under Short-Term

Pressure FX Impacts Main Driver Of YoY Variance

Net Profit Attributable to the owner of Net Profit Attributable to the owner of Parent Net

Parent Comparison Profit Comparison(Excluding FX Impact)

Unit: RMB million Unit: RMB million

-9.67%

6.005566.008.008.00736

5027.00+120.36%7.00

5.005.00

+12.61%+88.33%

6.006.00

4.004.00

3375.005.00452

299

3.003.004.004.00

334

3.003.00

2.002.00240

2.002.00

1.001.00

1.001.00

0.000.000.000.00

H1 2025 H1 2026 Q2 2025 Q2 2026 H1 2025 H1 2026 Q2 2025 Q2 2026Financial Highlights

H1 2026 Financial Performance Analysis (YoY)

Currency

H1 2026 H1 2025 % ▲ Note

RMB

North America and Europe markets

Sales Revenue 7441632955.92 6530775333.21 13.95%

growing rapidly

Higher Model C Business with

Gross Margin（%） 24.29% 21.42% 287bps improved gross margins across

major product lines

Revenue and gross margin rate both

EBITDA 1172692803.76 815410474.59 43.82%

up

Gross margin rate improvement and

EBITDA Profit（%） 15.76% 12.49% 327bps

optimized expense control

Net Profit Attributable to the FX losses weighed on parent net 501857209.50 555603360.29 -9.67%

Owner of Parent profit

Due to higher raw material

Net Operating Cash Flow 125085693.78 893182242.16 -86.00%

procurement

* H1 2026: Net Profit Attributable to the Parent at approximately RMB 502 million. Exchange rate-driven forex and hedging losses reduced profit by

approximately RMB 234 million. Excluding this adjusted Net Profit Attributable to the Parent at approximately RMB 736 million.* H1 2025: Net Profit Attributable to the Parent at approximately RMB 556 million. Exchange rate-driven forex and hedging gains increased profit by

approximately RMB 222 million. Excluding this adjusted Net Profit Attributable to the Parent at approximately RMB 334 million.Financial Highlights

H1 2026 Financial Performance Analysis (YoY)

Currency

H1 2026 H1 2025 % ▲ Note

RMB

Mainly due to increased employee

Selling & Distribution compensation sample expenses

Expenses 391376318.20 340844593.06 14.83% export credit insurance and travel

costs during the reporting period

Higher administrative expenses

General & Administrative mainly due to increased employee

Expenses 276698496.35 253142837.69 9.31% compensation IT costs and travel

costs

Primarily due to increased R&D

R&D Expenses 100152805.72 83428312.99 20.05% staff payroll during the reporting

period.Financial Highlights

Q2 2026 Financial Performance Analysis (YoY)

Currency

Q2 2026 Q2 2025 %

RMB ▲

Note

North America and Europe markets

Sales Revenue 4250442039.33 3844489498.82 10.56%

growing rapidly

Higher Model C shares with

Gross Margin（%） 24.67% 22.92% 175bps improved gross margins across

major product lines

Revenue and gross margin rate both

EBITDA 702832188.61 537959601.08 30.65%

up

Gross margin rate improvement and

EBITDA Profit（%） 16.54% 13.99% 255bps

optimized expense control

Net Profit Attributable to the Revenue growth and gross margin

Owner of Parent 336551087.03 298860730.79 12.61% improvement

Net Operating Cash Flow 767237442.94 959942509.21 -20.07% Due to higher inventory purchases

* Q2 2026: Net Profit Attributable to the Parent at approximately RMB 337 million. Exchange rate-driven forex and hedging losses reduced profit by

approximately RMB 115 million. Excluding this adjusted Net Profit Attributable to the Parent at approximately RMB 452 million.* Q2 2025: Net Profit Attributable to the Parent at approximately RMB 299 million. Exchange rate-driven forex and hedging gains increased profit by

approximately RMB 59 million. Excluding this adjusted Net Profit Attributable to the Parent at approximately RMB 240 million.Financial Highlights

Q2 2026 Financial Performance Analysis (YoY)

Currency

Q2 2026 Q2 2025 % ▲ NoteRMB

Mainly due to increased employee

Selling & Distribution

Expenses 207716703.41 179977396.99 15.41% compensation sample expenses

and registration fees

General & Administrative Mainly due to increased employee

Expenses 145413759.03 126886423.26 14.60% compensation and travel expenses

R&D Expenses 53763886.57 41949748.20 28.16% Primarily due to higher R&D payrollFinancial Highlights

H1 2026 New Global Registration Status by Geographic Segment

H1 2026 New Approvals:

500+

Latin North Middle Asia (China

Brazil Europe Oceania

America America East/Africa inclusive)

4.06%11.83%0.37%

31.98% 6.47% 15.90% 29.39%Financial Highlights

Total Global Registration Status by Geographic Segment as of June 2026

Total Approvals :

9400+

Latin North Middle Asia (China

Brazil Europe Oceania

America America East/Africa inclusive)

2.11%8.59%5.57%

40.62% 0.82% 16.49% 25.80%Financial Highlights

H1 2026 Revenue Status by Geographic Segment

H1 2026 Revenue：

7.442 billion RMB

Latin North Middle Asia (China

Brazil Europe Oceania

America America East/Africa inclusive)

H1 2026 18.56% 8.91% 6.24%26.69% 13.36% 9.91% 16.33%

Latin North Middle Asia (China

Brazil Europe Oceania

America America East/Africa inclusive)

H1 2025 25.56% 7.60% 5.37%25.55% 8.76% 10.76% 16.40%Financial Highlights

Revenue Share by Segment (YoY)

Revenue by Segment (H1) Quarterly Revenue by Segment

Model C Model C

Model C Model C

40.14% Model A + Model A + 41.35% Model A +

Model B 47.77%

Model A +

Model B 47.04% Model B

Model B

59.86%52.23%52.96%

58.65%

H1 2025 H1 2026 Q2 2025 Q2 2026Financial Highlights

Gross Margin Rate Comparison by Segment

Gross Margin Rate by Segment (H1) Quarterly Gross Margin Rate by Segment

35.00%

32.97%35.00%33.05%

30.21%31.54%

30.00%30.00%

25.00%25.00%

20.00%20.00%

16.36%16.84%17.23%

15.52%

15.00%15.00%

10.00%10.00%

5.00%5.00%

0.00%0.00%

Model A + Model B Model C Model A + Model B Model C

H1 2025 H1 2026 Q2 2025 Q2 2026Financial Highlights

Revenue by Product Category

Revenue by Product Category (H1) Revenue by Product Category (H1)

Other Other Other Other

1.36%1.93%1.49%1.50%

Fungicide Fungicide FungicideFungicide

10.33%10.01%10.75%10.02%

Insecticide Insecticide Insecticide

16.26% Insecticide 16.10% 16.20%

16.18%

Herbicide Herbicide Herbicide Herbicide

72.05%71.14%72.39%72.29%

H1 2025 H1 2026 Q2 2025 Q2 2026Financial Highlights

Gross Margin Rate Comparison by Product Category

Gross Margin Rate by Product Category (H1) Quarterly Gross Margin Rate by Product Category

35.00%35.00%

31.40%32.30%

30.86%

30.00%29.65%28.18%30.00%29.09%

27.25%

24.61%

25.00%25.00%

21.30%21.83%

20.71%

19.30%

20.00%20.00%

15.00%15.00%

10.00%10.00%

5.00%5.00%

0.00%0.00%

Herbicide Insecticide Fungicide Herbicide Insecticide Fungicide

H1 2025 H1 2026 Q2 2025 Q2 2026H1 2026 Operational Review Defining Global Brand Strategy Goals to 1 Strengthen Brand and Communications Capabilities

2025-2029 GLOBAL Brand Key Objective:

We are a China-born multinational crop

protection company with a global footprint.Building on This Goal:

* Significantly enhanced social media content

quality across all platforms and substantially

increased digital ad spend.* Advanced "factory marketing" initiatives

improving facility appearance and global visitor

reception to elevate the overall global brand

image.H1 2026 Operational Review Updating the Four Growth Pillars and Seed 2 Business– Progress Across All Core Fronts

2.1. Updating the Four Growth

Pillars and Seed Business

The 2026 strategic review further refined the "Four Growth Pillars" and"Seed Business.“Four Growth Pillars:

* Strengthening brand building and pursuing a multi-business-model

approach under a unified platform (with particular emphasis on

accelerating Model C business)

* Accelerating expansion into high-value markets particularly the EU

and North America

* Increasing the revenue share of insecticides and fungicides

* Forward-looking positioning and timely successful

commercialization of key newer active ingredients

Seed Business:

* Biologicals (Rainbow Bio)

* Non-crop products

* Exploration of innovative active ingredientsH1 2026 Operational Review Updating the Four Growth Pillars and Seed 2 Business– Progress Across All Core Fronts

2.2. Strengthening Brand

Building Model C Business

Accelerating Growth

The global brand communication strategy has

delivered initial results with LinkedIn

followers surpassing 120000.Model C business revenue share increased

from 40.14% in H1 2025 to 47.77% in the

reporting period with gross margin rising

from 30.21% to 32.97% underscoring the

growing strength of the high-margin business

model.H1 2026 Operational Review Updating the Four Growth Pillars and Seed 2 Business– Progress Across All Core Fronts

2.3. Accelerating Growth in EU and North

America Businesses

The combined revenue share of EU and North America operations

increased significantly from 14.08% in H1 2025 to 19.48% in the

reporting period reflecting the company's growing penetration in

high-barrier high-value markets.

2.4. Increasing Insecticide and Fungicide

Business

The combined revenue share of insecticides and fungicides rose

from 26.59% in H1 2025 to 26.93% in the reporting period

reflecting continued optimization and a more balanced product mix.H1 2026 Operational Review Updating the Four Growth Pillars and Seed 2 Business– Progress Across All Core Fronts

2.5. Seed Business Steady Progress

Rainbow Bio：

Following a "Model B first for light-structure entry then

Model C" approach the company is piloting operations in

target markets with favorable conditions aiming to achieve

self-sustaining growth while continuously refining localized

operational methodologies.NON CROP：

Currently in the global planning stage with active research

and identification efforts underway for target countries

market segments and product portfolios.Innovative Active Ingredients :

Exploration and research continue to advance.H1 2026 Operational Review Enhance Quality Boost Efficiency: Global 3 Marketing Network Expansion and Optimization

3.1. Strengthening the Performance

Orientation toward Commercial Success

During the reporting period the company adhered to the

overarching principle of "Enhance Quality Boost Efficiency"

and comprehensively optimized organizational

performance. By significantly increasing the weighting of

operational quality metrics—including gross margin net

profit after tax overdue accounts receivable and long-term

inventory—while correspondingly reducing the weighting of

sales revenue the company effectively steered frontline

market behavior.In addition the company continued to deepen overseas

organizational effectiveness initiatives dynamically

optimizing key roles such as general managers of

overseas subsidiaries. This has effectively stimulated

organizational vitality and operational performance.H1 2026 Operational Review Enhance Quality Boost Efficiency: Global 3 Marketing Network Expansion and Optimization

3.2. Talent Strategy and Corporate Culture Confidence

The company remains committed to its talent strategy embedding core values

across the full "recruit develop deploy retain" lifecycle. On the front line we

continue to deploy Chinese core staff as "upward-looking" ambassadors of

strategy culture and brand ensuring deep transmission of global strategy and

corporate culture.Currently most Model C subsidiaries operate under a "Commissar + Commander"

model (veteran Chinese expats paired with local leaders). This model

significantly enhancing the company's cultural confidence in global operations.On the talent development front programs such as the "Frontline Team Member

training" and "Rainbow Leadership Program" are accelerating the cultivation of

outstanding "Rainbow Ambassadors" through hands-on practice driving the team

toward a "professional credible accountable and collaborative" standard and

continuously reinforcing the value consensus underpinning global operations.H1 2026 Operational Review Enhance Quality Boost Efficiency: Global 3 Marketing Network Expansion and Optimization

3.3. Model C Subsidiary Delivers Stronger Operational

Performance

The company's Model C subsidiaries have steady performance improvement over

the past five years delivering strong and sustainable results as the global

operations system matures.

3.4. Forward-Looking Product Planning Ensures Timely

First-Mover Registration of High-Value Products

Through forward-looking selection of key newer active ingredients key newer

formulations and key differentiated formulations the company takes the lead in

global commercialization planning.In H1 2026 the company secured over 500 new registrations (including 35 in the

EU 17 in the US 18 in Canada and 22 in Brazil). As of June 30 2026 it held over

9400 crop protection registrations globally laying a solid foundation for early

commercialization in core markets.H1 2026 Operational Review First Generic Player for important New Active 4 Ingredients and Advanced Manufacturing Executed per Strategic Plan

4.1 Establishing "First Generic Player forImportant New Active Ingredients“ as a CoreCompetency

The company recognizes that being the first generic player for

important new active ingredients in core markets offers high

commercial value and significant competitive barriers.As one of the few global players with this capability we have made

this a strategic priority and established an end-to-end

commercialization mechanism covering the entire value chain:

screening registration R&D manufacturing supply and market

deployment.Currently approximately 30 selected key newer active ingredients

are advancing steadily and rapidly through this process in full

alignment with the planned timeline.H1 2026 Operational Review First Generic Player for important New Active 4 Ingredients and Advanced Manufacturing Executed per Strategic Plan

4.2 Active Ingredient Synthesis

Projects on Track

The company remains firmly committed to its active

ingredient manufacturing plan targeting an average

of at least two new active ingredient synthesis

projects commenced per year during the 2025–2029

strategic period.All projects scheduled for 2026 and 2027 have been

identified and are progressing steadily according to

plan.H1 2026 Operational Review First Generic Player for important New Active 4 Ingredients and Advanced Manufacturing Executed per Strategic Plan

4.3 Forward-Looking Formulation Capacity

Expansion to Ensure High-Quality On-Time

Delivery

To ensure high-quality low-cost and on-time delivery of global orders

the company is proactively expanding its formulation capacity.* The herbicide solid formulation workshop at the Weifang North Plant

was commissioned in H1 2026;

* The insecticide liquid formulation workshop at the Pingdu Plant is

expected to come on stream in H2 2026.The newly commissioned workshops have achieved significant

upgrades in flexible production continuous processing automation and

intelligence substantially improving production efficiency and product

consistency. This provides strong capacity support for high-quality fast

delivery to global markets.H1 2026 Operational Review FX Volatility and Rising Credit Risks in Select 5 Markets Weighed on Overall Performance

During the reporting period the RMB continued to

appreciate while currencies in countries such as

Brazil Argentina Australia Turkey Russia and India

experienced significant volatility. In H1 2026

exchange rate fluctuations reduced profit by

approximately RMB 234 million (compared to a

profit increase of approximately RMB 222 million in

H1 2025).Compounded by weak commodity prices rising

financing costs and extreme weather farm-gate

returns for growers in key crop protection markets

such as Brazil and Argentina have declined or even

turned negative while channel credit risks and

default rates remain elevated weighing on overall

performance.2026 Global Crop Protection

Industry Outlook

Industry Supply Continues to Grow; Major Crop Prices to Remain Soft with Geopolitical Tensions and FX Volatility

Active Ingredient Prices Expected to Inelastic End-User Demand and More Intensify Testing Supply Chain Agility

Fluctuate Near Bottom Fragmented Purchasing Patterns

Industry supply capacity continues to Global major crop prices are expected to Geopolitical developments crude oil

expand keeping market competition stay soft with growers placing greater prices and major currency exchange rate

active. Active ingredient prices are emphasis on input-output efficiency. fluctuations remain key market variables

expected to remain range-bound at the with the potential to periodically disrupt

bottom as the sector navigates a The "low-inventory late-purchasing" industry chain costs and supply-demand

cyclical trough of capacity consolidation procurement habits are likely to persist dynamics amplify price volatility and

and profit reshaping. making demand patterns more increase the difficulty of pricing and

fragmented. This trend places higher inventory management. As a result global

demands on supply chain agility and resource allocation capabilities and rapid

refined inventory management across the response capacity are becoming

industry. increasingly critical.

1 2 32026 Global Crop Protection

Industry Outlook

Generic Crop Protection Share Industry Competition Evolving into a Policy and Trade Environment

Expected to Rise Further Structural Comprehensive Capability Contest; Remain Complex and Fluid Making

Opportunities Emerging Concentration Among Leading Global Operational Capabilities

Players Expected to Accelerate Increasingly Critical

As global agricultural input costs rise As more Chinese companies accelerate Changes in trade policies tariffs access

and growers place greater emphasis on their international expansion global regulations and export rebate

input-output efficiency cost-effective market share will increasingly concentrate adjustments across multiple countries

generic crop protection products are among players with a complete industrial may periodically disrupt international

expected to gain more traction with chain strong registration capabilities and trade patterns and market supply-demand

market share set to increase further. a global marketing network. Industry dynamics. Amid rising uncertainty in the

The global market landscape continues competition is shifting from a pure price operating environment companies'

to tilt toward generics presenting clear game to a comprehensive contest of full- globally-localized operational capabilities

structural opportunities for leading chain coordination brand building and will serve as a core moat to weather

Chinese exporters. global operational capabilities. external risks and sustain steady growth.

4 5 62026 Business Outlook

1 Steadfast Execution of 2 Prioritizing Operational Quality Business Mix Optimization Strategic Plan Core over Blind Scale Expansion 3 to Drive Continued Gross

Operating Metrics on a Margin Expansion

Steady Upward Trajectory

In line with the 2025-2029 mid-term Amid a complex environment of continued With the parallel development of multiple

strategic plan and 2026 targets the industry supply growth active market business models under the Business

company will continue to focus on competition declining farm-gate returns Solution Platform—particularly the“enhance quality boost efficiency." On a and rising credit risk along the industrial continued growth of Model C revenuetrajectory of sustained operational chain the company will continue to adhere share—alongside an increasing

quality improvement core metrics to its core principle of "enhancing quality contribution from high-value markets

including full-year parent net profit gross and boosting efficiency." With commercial such as North America and the EU and

margin EBITDA and revenue are success as the guiding objective the the gradual approval of high-value product

expected to deliver steady growth. company will place operational quality registrations in key global markets the

improvement at the center of its efforts company's profit structure is set to further

refrain from pursuing simple revenue scale improve positioning gross margin for a

expansion and continuously consolidate its continued upward trend.core competitive advantages.2026 Business Outlook

First Generic Player for Geopolitical Tensions FX

4 5 Accelerating AI Adoption Important New Active 6 Volatility and Trade Policy to Drive Organizational Ingredients and Complexity: Strengthening Risk

Efficiency

Advanced Manufacturing to Management Capabilities

Fuel New Growth Drivers

The company has identified "First Generic The company is leveraging AI as a key driver of organizational Geopolitical developments crude oil prices and

Player for Important New Active Ingredients" as efficiency: major currency exchange rate fluctuations

a core competency and a new growth pillar 1. Complete AI use-case mapping and incorporate advanced AI remain key market variables that may periodically

with several such ingredients already achieving proficiency into future job qualification standards to encourage disrupt industry chain costs and supply-demand

successful first-to-market generic launches in broad adoption. dynamics amplify price volatility and increase

2. Scale up the promotion of best practices embedding AI into

key markets this year. the difficulty of pricing and inventory

workflows across registration documentation market

intelligence supply chain analytics financial data processing management. Meanwhile changes in tariffs

and dashboard development. access rules and export rebate policies across

3. Introduce cost-effective AI foundation models with multiple countries may also periodically affect

At the same time R&D-driven advanced

standardized usage protocols providing all employees with a international trade patterns. In the face of

manufacturing capabilities continue to advance unified and accessible application gateway. growing uncertainty in the operating environment

effectively helping the company increase global the company will continue to strengthen its

market share enhance industry influence and global operational and risk management

further improve overall gross margin levels. Currently AI has been progressively integrated into multiple core capabilities to ensure steady business

business processes with marked improvements in AI performance.awareness and organizational efficiency across the workforce.Mid-Term Strategic Plan (2025-2029)

"Enhance Quality Boost Efficiency"Mid-Term Strategic Plan (2025-2029)-2026 Update

4 Strategic Growth Pillars

Foster Multi-business Model Accelerating Europe &

Synergy on Business Solution North America High-Value

Platform & Increase Model C Market Expansion

Business

12

Increased Insecticide & Forward-Looking

Fungicide Business Positioning and Timely

Commercialization of

important New Active

3 Ingredients 4Mid-Term Strategic Plan (2025-2029)-2026 Update

6 Critical Tasks

Proactive Product Planning & Commercialization: Through forward-looking product planning identify

1. important products—especially important new active ingredients and differentiated products. Spearhead

global registration layout strategic coordination and commercialization readiness to ensure these

products achieve regulatory approval and successful commercialization ahead of peers in selected core

and important countries.R&D Pipeline & Self-synthesized Strategy: Drive the R&D manufacturing and supply of important new

2. active ingredients through rigorous pipeline management aiming to be the first generic player in their

priority countries. Simultaneously execute the development of other planned self-synthesized active

ingredients and continuously deepen our expertise in existing self-synthesized active ingredients."Four-in-one" Formulation development System: Operate and continuously refine a scenario-based "four-

3. in-one" formulation development system. Enhance highly adaptable and efficiently collaborative

formulation capabilities to support product registration delivery and successful commercialization.Mid-Term Strategic Plan (2025-2029)-2026 Update

6 Critical Tasks

Multi-Business Model Balanced Growth: Uphold a multi-business-model approach based on business

4. solution platform continuously strengthen brand building and focus on improving operational quality

driving rapid growth in start-up core countries and ensuring the timely successful commercialization of

important—especially important new products to guarantee healthy and balanced business growth.Supply Chain Product Manager & Resilient Supply: Empower Supply Chain Product Managers as the

5. business engine. Achieve rapid response and decisive accurate decision-making through deep end-to-

end understanding of the entire industry chain. Implement differentiated supply assurance for important

new important commodity important niche active ingredients to build a safe sustainable and

competitive global supply chain.Lean Operations & Agile Delivery: Leverage forward-looking capacity planning and a lean operational

6. system. Scientifically schedule orders and strictly control end-to-end quality and costs ensuring high-

quality cost-effective and fast on-time global delivery through efficient and agile fulfillment capabilities.Mid-Term Strategic Plan (2025-2029)-2026 Update

5 Key Capability Gaps

1 Global Operations Management

2 Successful Commercialization of Differentiated Products

3 First Generic Player for Important New Active Ingredients

4 Brand Business Development

5 Product Manager-Driven Global Supply ChainTo be a Global Leading Crop

Protection Company

THANK YOU